BioMed Research International / 2015 / Article / Tab 1

Research Article

Secretome Identifies Tenascin-X as a Potent Marker of Ovarian Cancer

Table 1

Pearson’s correlation between differentially secreted protein determined by LC-MS/MS (unique spectrum count) and circulating CA-125 in a follow-up patient study. Und = undetermined.

ABCD Pearson’s/CA-125

MMP-26251116−0.616
Vimentin10131712−0.670
IGF binding151013130.630
Gelsolin3552−0.228
Thrombospondin-10542−0.744
Complement C313472791040.802
Nucleobindin 198660.853
DKK34444Und
IGF binding14118180.117
CK8271325160.613
Plasminogen activator inhibitor351933290.463
MMP inhibitor 25655−0.205
Collagen alpha 2 (VI) chain0204−0.559
CK72647150.812
Ezrin20713150.679
Aldose reductase1671370.755
Retinoic acid response107670.959
Complement factor B412633460.212
Complement factor I98470.655
Sulfhydryl oxidase I221418230.318
Fibrillin 160230.788
Antileukoproteinase921917−0.355
Endothelial protein C receptor43050.274
Beta-1,4-Galactosyltsferase 150520.474
Calretinin54520.531
Carboxypeptidase A42457140.828
Tenascin-X12 4 3 2 0.999
Agrin22141520.768
Superoxide dismutase43720.003
Coiled-coil domain6965−0.053
UTP-glc-1P uridylyl transferase22200.432
Laminin subunit232314180.612
Matrix remodeling associated610103−0.137
CK1921131690.849
Alpha 2 macroglobulin10304121−0.751
HSP1020000.990

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.